WATCH THE VIDEO HERE Mounjaro® (tirzepatide) will be available in the market from the end of May 2025 BANGKOK, THAILAND – Media OutReach Newswire – 27 May 2025 – Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro® (tirzepatide), the innovative obesity and diabetes medicine developed by Eli Lilly and Company, will be launched in […]
Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand
